Acute Hematogenous Osteomyelitis in Children

Nimmy Thakolkaran1, Avinash K Shetty2

  • 1Department of Family Medicine, Mount Sinai Hospital, Chicago, IL.

Ochsner Journal
|July 2, 2019
PubMed

Insights

Acute hematogenous osteomyelitis (AHO) in children is evolving, with Staphylococcus aureus as the primary pathogen. Management requires an individualized, multidisciplinary approach considering pathogen changes and disease complexity.

Area of Science:

  • Pediatric Infectious Diseases
  • Orthopedic Surgery
  • Microbiology

Background:

  • Epidemiology of acute hematogenous osteomyelitis (AHO) in children has shifted.
  • Increasing recognition of community-associated methicillin-resistant Staphylococcus aureus (MRSA) as a cause of severe pediatric AHO.

Purpose of the Study:

  • To review current literature on pediatric AHO.
  • To outline epidemiology, microbiology, pathogenesis, clinical presentation, diagnosis, and antimicrobial management.

Main Methods:

  • Literature review of current research on pediatric AHO.
  • Analysis of epidemiological trends, causative pathogens, diagnostic modalities, and treatment strategies.

Main Results:

  • Staphylococcus aureus is the most common pathogen, followed by group A Streptococcus (GAS).
  • MRSA infections can lead to severe, complicated AHO.
  • Culture and PCR are key for pathogen identification; MRI is the preferred imaging modality.
  • Antibiotic choices vary based on pathogen (MRSA, MSSA, K. kingae, GAS, S. pneumoniae) and disease severity.

Conclusions:

  • Management of pediatric AHO requires an individualized, multidisciplinary approach due to evolving pathogens and variable disease presentations.
  • Treatment duration and modality (medical vs. surgical) depend on disease complexity and causative organism.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
263
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.0K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
907
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
479